Episodios

  • Ep. 43 The metaverse: a new frontier for rheumatology
    Apr 10 2024

    Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients.

    Listen now to hear about the current technological developments and what this means for future clinical practice!

    You can read this article [https://doi.org/10.1093/rheumatology/kead534] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    11 m
  • Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?
    Jan 11 2024

    Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.

    Listen now to hear the findings and what this means for future clinical practice!

    You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    18 m
  • Ep 41. Addressing the leaky pipeline
    Jan 4 2024

    What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology.

    Want to read more? Here's your further reading list:
    1. Read Christina and Isabella's full paper
    2. Read Latika's work on the gender gap in journal Editorial Boards

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    18 m
  • Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy
    Dec 21 2023

    We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see.

    Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly productive term as Editor-in-Chief in February 2024.

    Want to discuss a potential article? Email editorial@rheumatology.org.uk.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    5 m
  • Ep 39. UK JIA Biologics Register: stopping biologics for remission
    Nov 30 2023

    What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register.

    Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London.

    Managed by the University of Manchester, the UK JIA Biologics Register is a collaboration between BSR and Versus Arthritis that measures the safety and effectiveness of biologic and biosimilar treatment for juvenile idiopathic arthritis.

    Want to find out more? Here's your further reading list:
    1. Read Lianne and Coziana's full paper
    2. Find out more about the UK JIA Biologics Register
    3. Explore research from the BSR biologics registers

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    10 m
  • Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study
    Oct 26 2023

    Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDMARD-IR).

    Listen now to hear the findings and what this means for future clinical practice!

    You can read this article [https://doi.org/10.1093/rheumatology/keac605] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    7 m
  • Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes?
    Oct 18 2023

    Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination.

    Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for poor functional and radiological outcomes.

    You can read this article [https://doi.org/10.1093/rap/rkad048] in Rheumatology Advances in Practice.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    13 m
  • Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland
    Oct 11 2023

    Can patients with rheumatoid arthritis examine their own joints?

    Dr David Liew talks to Dr Charlotte Sharp and Karen Staniland about their work to create a video teaching patients how to self-examine tender and swollen joints.

    Charlotte is now a consultant rheumatologist based in Manchester and has an interest in applied health research. Karen is the patient and public involvement lead for the REMORA project and has rheumatoid arthritis. Their paper was a winning entry to the 2023 Rheumatology Advances in Practice Trainee Publishing Programme.

    Read the article: How to self-examine for tender and swollen joints: co-producing a training video for people with rheumatoid arthritis

    You can also watch the video or find out more about the REMORA project.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos
    19 m